CLUES FOR THE ATTENUATION OF DEGLYCOSYLATED MUTANT OF SIV239 IN THE PRIMARY INFECTION

¹CREST, Japan Science and Technology Agency, Kawaguchi, Saitama; ²Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Tsukuba, Ibaraki; ³AIDS Research Center, National Institute of Infectious Diseases, Shinjuku, Tokyo; ⁴Corporation for Production and Research of Laboratory Primates, Tsukuba, Ibaraki; ⁵Center for Chronic Viral Diseases, Kagoshima University, Kagoshima, Kagoshima; ⁶Center of Research Network for Infectious Diseases, RIKEN, Chiyoda, Tokyo; ⁷School of Pharmaceutical, University of Shizuoka, Shizuoka, Japan.